BELLICUM PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-2.31% | -53.99% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
822 121
Capitalization (USD)
822 121
Net sales ()
1 500 000
Number of employees
13
Sales / Employee (USD)
115 385
Free-Float
98.45 %
Free-Float capitalization (EUR)
791 903
Free-Float capitalization (USD)
791 903
Highs and lows
Current year
0.00
0.13
1 year
0.000.19
3 years
0.000.19
5 years
0.000.19
10 years
0.000.19
Indicators
Moving average 5 days
0.07
Moving average 20 days
0.07
Moving average 50 days
0.09
Moving average 100 days
0.11
RSI 9 days
42.68
RSI 14 days
42.33
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | -2.31% | - | - | 822K | ||
| +1.36% | +2.64% | +12.30% | +36.87% | 116B | ||
| +0.45% | +0.28% | +12.15% | +33.58% | 106B | ||
| -2.07% | +7.00% | -8.14% | -12.73% | 23.89B | ||
| +0.66% | -0.65% | -1.69% | -10.50% | 21.58B | ||
| -4.86% | -5.61% | -10.60% | -32.05% | 18.96B | ||
| -1.25% | -4.79% | -41.25% | -37.86% | 16.96B | ||
| -2.22% | -11.65% | -15.33% | -35.43% | 16.33B | ||
| -0.79% | -2.03% | +5.80% | +50.52% | 14.14B | ||
| -2.89% | -6.03% | +28.03% | -6.01% | 12.02B | ||
| -0.72% | -1.83% | -2.52% | +24.90% | 7.58B | ||
| -0.74% | -7.79% | +9.49% | +34.98% | 7.54B | ||
| +0.75% | +7.67% | +3.54% | +46.84% | 7.42B | ||
| +4.84% | -8.30% | -31.18% | -37.30% | 7.2B | ||
| -3.42% | -11.52% | -57.97% | -71.95% | 6.86B | ||
| +1.92% | -6.34% | +237.18% | +187.05% | 6.79B | ||
| Average | -0.56% | -2.83% | +9.32% | +11.40% | ||
| Weighted average by Cap. | -0.02% | -0.19% | +7.24% | +19.09% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -53.99% | ||
| 2023 | +20.00% |
- Stock Market
- Equities
- BPXA Stock
- Quotes Bellicum Pharmaceuticals, Inc.
